TELEHEALTH
AS PRIMARY CARE PHARMACISTS IN THE WESTERN ISLES BEGIN TO CARRY OUT MEDICINES REVIEWS IN GP PRACTICES, SP SPEAKS TO DAWN TIERNAN, CHIEF PHARMACIST AT NHS WESTERN ISLES HOSPITAL, ABOUT THE VERY SUCCESSFUL PILOT BEHIND THIS MOVE…
PHARMACY AND PATIENT: FACE TO FACE T
he appointment of Liam Callaghan as NHS Western Isles first primary care pharmacist
(PCP) is the result of a very successful pilot, which ran on the islands over a six-month period last year.
Based at Harris and Lewis, with regular visits to the southern isles, Liam carries out medicines reviews with patients on a face-to-face basis, supporting GPs in both simple and complex pharmacy issues.
Prescription for Excellence stated as 36 - SCOTTISH PHARMACIST
one of its goals that all pharmacists providing NHS pharmaceutical care will be NHS-accredited clinical pharmacist independent prescribers working in collaborative partnerships with medical practitioners who will continue to have overall responsibility for diagnosis.
In remote areas such as the Western Isles of Scotland, such collaboration between medical practitioners is even more vitally important.
At the end of 2014, Chief Pharmacist,
Dawn Tiernan, raised the idea of including NHS-accredited clinical pharmacists into the primary care team with a view to increasing the clinical capacity and assisting in addressing the increasing demands in primary care in terms of population age and complexity of care.
As a result, NHS Western Isles (WI) submitted a business case to Scottish Government for funding to look at the feasibility of providing pharmaceutical care for patients registered with
dispensing doctors within WI using remote technology.
‘At that time,’ Dawn told SP, ‘there were no independent pharmacist prescribers in primary care in WI. We therefore had to use the skills of clinical pharmacists, who were employed in secondary care - one of which was an independent pharmacist prescriber then specialising in cardiology and antimicrobials, and another, who qualified during the pilot and who specialised in diabetes.’
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
